<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35392458</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2328-8957</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>9</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Open forum infectious diseases</Title>
          <ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Low Rates of Contraception Use in Women With Human Immunodeficiency Virus.</ArticleTitle>
        <Pagination>
          <StartPage>ofac113</StartPage>
          <MedlinePgn>ofac113</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">ofac113</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofac113</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Women with human immunodeficiency virus (WWH) have low rates of hormonal or long-acting contraceptive use. Few studies have described contraception use among WWH over time.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We examined contraception (including all forms of hormonal contraception, intrauterine devices, and bilateral tubal ligations) use among cisgender women aged 18-45 years in care at Vanderbilt's human immunodeficiency virus (HIV) clinic in Nashville, Tennessee, from 1998 through 2018. Weighted annual prevalence estimates of contraception use were described. Cox proportional hazards models examined factors associated with incident contraception use and pregnancy.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of the 737 women included, median age at clinic entry was 31 years; average follow-up was 4.1 years. At clinic entry, 47 (6%) women were on contraception and 164 (22%) were pregnant. The median annual percentage of time on any contraception use among nonpregnant women was 31.7% and remained stable throughout the study period. Younger age was associated with increased risk of pregnancy and contraceptive use. Psychiatric comorbidity decreased likelihood of contraception (adjusted hazard ratio [aHR], 0.52 [95% CI {confidence interval}, .29-.93]) and increased likelihood of pregnancy (aHR, 1.77 [95% CI, .97-3.25]). While not associated with contraceptive use, more recent year of clinic entry was associated with higher pregnancy risk. Race, substance use, CD4 cell count, HIV RNA, smoking, and antiretroviral therapy were not associated with contraception use nor pregnancy.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Most WWH did not use contraception at baseline nor during follow-up. Likelihood of pregnancy increased with recent clinic entry while contraception use remained stable over time. Continued efforts to ensure access to effective contraception options are needed in HIV clinics.</AbstractText>
          <CopyrightInformation>Â© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bhatta</LastName>
            <ForeName>Manasa</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>School of Medicine, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bian</LastName>
            <ForeName>Aihua</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Norwood</LastName>
            <ForeName>Jamison</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Disease, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shepherd</LastName>
            <ForeName>Bryan E</ForeName>
            <Initials>BE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ransby</LastName>
            <ForeName>Imani</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Disease, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nelson</LastName>
            <ForeName>Jeffrey</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Disease, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Turner</LastName>
            <ForeName>Megan</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Disease, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sterling</LastName>
            <ForeName>Timothy R</ForeName>
            <Initials>TR</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Disease, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Castilho</LastName>
            <ForeName>Jessica L</ForeName>
            <Initials>JL</Initials>
            <Identifier Source="ORCID">0000-0002-7599-8173</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Disease, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>K23 AI120875</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P30 AI110527</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UL1 TR002243</GrantID>
            <Acronym>TR</Acronym>
            <Agency>NCATS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Open Forum Infect Dis</MedlineTA>
        <NlmUniqueID>101637045</NlmUniqueID>
        <ISSNLinking>2328-8957</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">HIV</Keyword>
        <Keyword MajorTopicYN="N">contraception</Keyword>
        <Keyword MajorTopicYN="N">family planning</Keyword>
        <Keyword MajorTopicYN="N">pregnancy</Keyword>
        <Keyword MajorTopicYN="N">women</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>8</Day>
          <Hour>5</Hour>
          <Minute>22</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35392458</ArticleId>
        <ArticleId IdType="pmc">PMC8982767</ArticleId>
        <ArticleId IdType="doi">10.1093/ofid/ofac113</ArticleId>
        <ArticleId IdType="pii">ofac113</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Breskin A, Adimora AA, Westreich D.. 
Women and HIV in the United States.
PLoS One
2017; 12:e0172367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5313170</ArticleId>
            <ArticleId IdType="pubmed">28207818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Joint United Nations Programme on HIV/AIDS.
UNAIDS report on the global AIDS epidemic 2013. https://www.unaids.org/en/resources/documents/2013/20130923_UNAIDS_Global_Report_2013. Accessed 9 September 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>
Joint United Nations Programme on HIV/AIDS.
When women lead, change happens: women advancing the end of AIDS, 2017. https://www.unaids.org/en/resources/documents/2017/when-women-lead-change-happens. Accessed 9 September 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>
Gipson JD, Koenig MA, Hindin MJ.. 
The effects of unintended pregnancy on infant, child, and parental health: a review of the literature.
Stud Family Planning
2008; 39:18â38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18540521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Halperin DT, Stover J, Reynolds HW.. 
Benefits and costs of expanding access to family planning programs to women living with HIV.
AIDS
2009; 23:S123â30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20081384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Patel RC, Bukusi EA, Baeten JM.. 
Current and future contraceptive options for women living with HIV.
Expert Opin Pharmacother
2018; 19:1â12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5963879</ArticleId>
            <ArticleId IdType="pubmed">28891343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Haddad LB, Wall KM, Mehta CC, et al. . Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative women. Am J Obstet Gynecol 2017; 216:71.e1â16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5182149</ArticleId>
            <ArticleId IdType="pubmed">27640942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pereira GFM, Kim A, Jalil EM, et al. . Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study. Lancet HIV 2021; 8:e33â41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7869891</ArticleId>
            <ArticleId IdType="pubmed">33387477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zash R, Makhema J, Shapiro RL.. 
Neural-tube defects with dolutegravir treatment from the time of conception.
N Engl J Med
2018; 379:979â81.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6550482</ArticleId>
            <ArticleId IdType="pubmed">30037297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Reynolds HW, Janowitz B, Homan R, Johnson L.. 
The value of contraception to prevent perinatal HIV transmission.
Sex Transm Dis
2006; 33:350â6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16505747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brittain K, Phillips TK, Zerbe A, Abrams EJ, Myer L.. 
Long-term effects of unintended pregnancy on antiretroviral therapy outcomes among South African women living with HIV.
AIDS
2019; 33:885â93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6528830</ArticleId>
            <ArticleId IdType="pubmed">30649049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brittain K, Mellins CA, Remien RH, et al. . HIV-status disclosure and depression in the context of unintended pregnancy among South African women. Glob Public Health 2019; 14:1087â97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6557665</ArticleId>
            <ArticleId IdType="pubmed">30584810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Meyer JP, Womack JA, Gibson B.. 
Beyond the pap smear: gender-responsive HIV care for women.
Yale J Biol Med
2016; 89:193â203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4918880</ArticleId>
            <ArticleId IdType="pubmed">27354845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sun M, Peipert JF, Zhao Q, et al. . Trends in contraceptive use among women with human immunodeficiency virus. Obstet Gynecol 2012; 120:783â90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3449062</ArticleId>
            <ArticleId IdType="pubmed">22996095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Stanwood NL, Cohn SE, Heiser JR, Pugliese M.. 
Contraception and fertility plans in a cohort of HIV-positive women in care.
Contraception
2007; 75:294â8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2020512</ArticleId>
            <ArticleId IdType="pubmed">17362709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Teodoro N, Fu A, Ohly NT, Shalev N, Matseoane-Peterssen D, Westhoff CL.. 
Long-acting reversible contraception knowledge, attitudes and use among HIV-infected and -uninfected women and their providers.
Contraception
2019; 100:269â74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31226320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Massad LS, Evans CT, Wilson TE, et al. . Contraceptive use among U.S. women with HIV. J Womens Health (Larchmt) 2007; 16:657â66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17627401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Haddad LB, Monsour M, Tepper NK, Whiteman MK, Kourtis AP, Jamieson DJ.. 
Trends in contraceptive use according to HIV status among privately insured women in the United States.
Am J Obstet Gynecol
2017; 217:676.e1â11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6674982</ArticleId>
            <ArticleId IdType="pubmed">28866122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sheth AN, Angert CD, Haddad LB, Mehta CC, Cohn SE.. 
Contraception methods used among women with HIV starting antiretroviral therapy in a large United States clinical trial, 2009-2011.
Contraception
2021; 103:225â31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7925358</ArticleId>
            <ArticleId IdType="pubmed">33189709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Stanback J, Steiner M, Dorflinger L, Solo J, Cates W Jr. WHO tiered-effectiveness counseling is rights-based family planning. Glob Health Sci Pract 2015; 3:352â7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4570010</ArticleId>
            <ArticleId IdType="pubmed">26374797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shepherd BE, Rebeiro PF, Caribbean C; Caribbean, Central and South America Network for HIV Epidemiology. Brief report: assessing and interpreting the association between continuous covariates and outcomes in observational studies of HIV using splines. J Acquir Immune Defic Syndr 2017; 74:e60â3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5303133</ArticleId>
            <ArticleId IdType="pubmed">27798430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rubin DB.
Multiple Imputation for Nonresponse in Surveys.
New York, NY: John Wiley &amp; Sons, Inc;1987.</Citation>
        </Reference>
        <Reference>
          <Citation>
Kavanaugh ML, Jerman J.. 
Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014.
Contraception
2018; 97:14â21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5959010</ArticleId>
            <ArticleId IdType="pubmed">29038071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Haddad LB, Machen LK, Cordes S, et al. . Future desire for children among women living with HIV in Atlanta, Georgia. AIDS Care 2016; 28:455â9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26702869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Raziano VT, Smoots AN, Haddad LB, Wall KM.. 
Factors associated with sterilization among HIV-positive US women in an urban outpatient clinic.
AIDS Care
2017; 29:612â7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27915483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Womack JA, Novick G, Goulet JL.. 
Hormonal contraceptive use in HIV-infected women using antiretroviral therapy: a systematic review.
Open Access J Contracept
2015; 6:37â520.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5611808</ArticleId>
            <ArticleId IdType="pubmed">28955156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Panel on Antiretroviral Guidelines for Adults and Adolescents.
Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services.2022:J68â9. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf. Accessed 9 February 2022. </Citation>
        </Reference>
        <Reference>
          <Citation>
Alene KA, Atalell KA.. 
Contraceptive use and method preference among HIV-positive women in Amhara region, Ethiopia.
BMC Womens Health
2018; 18:97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6006570</ArticleId>
            <ArticleId IdType="pubmed">29914445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Budhwani H, Hearld KR, Dionne-Odom J, et al. . HIV status and contraceptive utilization among women in Cameroon. J Int Assoc Provid AIDS Care 2019; 18:2325958219826596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6748529</ArticleId>
            <ArticleId IdType="pubmed">30776955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Francis J, Malbon K, Braun-Courville D, Lourdes LO, Santelli J.. 
Ambivalence about pregnancy and its association with symptoms of depression in adolescent females initiating contraception.
J Adolesc Health
2015; 56:44â51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25200344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Patel PR, Laz TH, Berenson AB.. 
Patient characteristics associated with pregnancy ambivalence.
J Womens Health (Larchmt)
2015; 24:37â41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4346234</ArticleId>
            <ArticleId IdType="pubmed">25454635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dunkel Schetter C, Tanner L.. 
Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice.
Curr Opin Psychiatry
2012; 25:141â8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4447112</ArticleId>
            <ArticleId IdType="pubmed">22262028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Grady CD, Dehlendorf C, Cohen ED, Schwarz EB, Borrero S.. 
Racial and ethnic differences in contraceptive use among women who desire no future children, 2006â2010 National Survey of Family Growth.
Contraception
2015; 92:62â70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4468010</ArticleId>
            <ArticleId IdType="pubmed">25863228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Murray Horwitz ME, Ross-Degnan D, Pace LE.. 
Contraceptive initiation among women in the United States: timing, methods used, and pregnancy outcomes.
Pediatrics
2019; 143:e20182463.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6361349</ArticleId>
            <ArticleId IdType="pubmed">30647089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
American College of Nurse-Midwives, National Association of Nurse Practitioners in Womenâs Health, American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine.
Interpregnancy care.
Am J Obstet Gynecol
2019; 220:B2â18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30579872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Judge-Golden CP, Borrero S, Zhao X, Mor MK, Callegari LS.. 
The association between mental health disorders and history of unintended pregnancy among women veterans.
J Gen Intern Med
2018; 33:2092â9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6258629</ArticleId>
            <ArticleId IdType="pubmed">30187377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Borrero S, Callegari LS, Zhao X, et al. . Unintended pregnancy and contraceptive use among women veterans: the ECUUN study. J Gen Intern Med 2017; 32:900â8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5515789</ArticleId>
            <ArticleId IdType="pubmed">28432564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hall KS, Kusunoki Y, Gatny H, Barber J.. 
The risk of unintended pregnancy among young women with mental health symptoms.
Soc Sci Med
2014; 100:62â71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3898511</ArticleId>
            <ArticleId IdType="pubmed">24444840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cleland K, Peipert JF, Westhoff C, Spear S, Trussell J.. 
Family planning as a cost-saving preventive health service.
N Engl J Med
2011; 364:e37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21506736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kang-Yi CD, Kornfield SL, Epperson CN, Mandell DS.. 
Relationship between pregnancy complications and psychiatric disorders: a population-based study with a matched control group.
Psychiatr Serv
2018; 69:300â7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5937933</ArticleId>
            <ArticleId IdType="pubmed">29137553</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
